Lorus Therapeutics reports strong meta-analysis results for Virulizin, prepares for phase III trials June 28, 2000
Tumor-associated antigen-derived immunogenic polypeptides useful for cancer immunotherapy June 23, 2000
Phase I trial of Hu1D10 continues following positive results in first lymphoma patients treated May 29, 2000
RSS